Cytokinetics (CYTK) Stock Price

$44.55 4.3%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    2

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Cytokinetics, AI stock picks, stock alerts and much more.

Sign up

CYTK AI Stock Analysis

AI stock analysis for CYTK is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Cytokinetics (CYTK) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Cytokinetics (CYTK) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Cytokinetics (CYTK), currently trading at $44.55, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About CYTK

LSE

  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases.

  • Symbol

    CYTK

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    5.3B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $25.72
0.1%
5
INO Inovio Pharmaceuticals
INO		 $1.81
3.7%
2
MRNA Moderna
MRNA		 $33.85
0.9%
3
AVXL Anavex Life Sciences
AVXL		 $9.56
0.5%
5
BBIO BridgeBio Pharma
BBIO		 $36.74
1.3%
5

News

Cytokinetics (CYTK) Moves 5.4% Higher: Will This Strength Last?

Cytokinetics (CYTK) Moves 5.4% Higher: Will This Strength Last?
March 24, 2025. zacks.com
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community

Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
March 20, 2025. globenewswire.com
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo

Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo
March 17, 2025. globenewswire.com
Cytokinetics Nears Approval: 'Buy' The New Potential Cardiology Franchise With Aficamten

Cytokinetics Nears Approval: 'Buy' The New Potential Cardiology Franchise With Aficamten
March 16, 2025. seekingalpha.com

CYTK Alternative Data

Web Traffic

Cytokinetics receives an estimated 23076 monthly visitors to cytokinetics.com.

  • Web Traffic

    23076

  • Change from Previous Month

    5.2%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Cytokinetics was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    100%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

Reddit Mentions

Cytokinetics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

Twitter Followers

Cytokinetics has 1,753 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    1753

  • Daily Change

    0.1%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.6%

  • YoY Change

    0.6%

Facebook Engagement

Cytokinetics has engaged 11 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    11

  • Daily Change

    0%

  • 1 Month Change

    26.7%

  • 3 Month Change

    1000%

  • YoY Change

    1000%

Youtube Subscribers

Cytokinetics has 469 subscribers on its main Youtube channel, up by 1.5% over the last month.

  • Youtube Subscribers

    469

  • Daily Change

    0%

  • 1 Month Change

    1.5%

  • 3 Month Change

    1.7%

  • YoY Change

    1.7%

LinkedIn Followers

31,766 are following Cytokinetics on LinkedIn, up by 3.8% over the last month.

  • LinkedIn Followers

    31766

  • Daily Change

    0.2%

  • 1 Month Change

    3.8%

  • 3 Month Change

    12.3%

Job Postings

Cytokinetics currenly has an estimated 38 open job postings, up by 5.6% over the last month.

  • Job Postings

    38

  • Daily Change

    11.8%

  • 1 Month Change

    5.6%

  • 3 Month Change

    2.6%

  • YoY Change

    2.6%

LinkedIn Employees

According to LinkedIn, Cytokinetics has 563 employees, up by 1.1% over the last month.

  • LinkedIn Employees

    563

  • Daily Change

    0.2%

  • 1 Month Change

    1.1%

  • 3 Month Change

    2.7%

  • YoY Change

    2.7%

Business Outlook

According to employee reviews, the business outlook among employees at Cytokinetics is 58 out of 100 (neutral).

  • Business Outlook

    58

  • Change from Previous Month

    28.9%

  • 3 Month Change

    0%

  • YoY Change

    0%

CYTK Financials

CYTK Key Metrics

  • Total Revenue

    $16.9M

  • Net Income

    -$150M

  • Earnings per Share

    -$1.34

  • Free cash flow

    -$66.9M

  • EBITDA

    -$125M

  • EBITDA Ratio

    -7.38719

  • Total Assets

    $1.4B

CYTK 2-year Revenue & Income
CYTK 2-year Free Cash Flow

CYTK Technicals

CYTK SMA
CYTK RSI

FAQ

What's the current price of Cytokinetics (CYTK) Stock?
The price of an Cytokinetics (CYTK) share is $44.55.

What's the market cap of Cytokinetics?
The current market cap of Cytokinetics is 5.3B.

Should I buy or sell CYTK?
Cytokinetics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Cytokinetics is better viewed as a hold or accumulate position while waiting for further developments.

Is Cytokinetics a good investment?
The current analysis of Cytokinetics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Cytokinetics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Cytokinetics (CYTK) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Cytokinetics stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Cytokinetics (CYTK) that investors often compare it to?
Cytokinetics (CYTK) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Cytokinetics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Cytokinetics' stock price to be around $44.84 in 2026. Starting from the current price of $44.55, this represents a 0.6% change in price, indicating a neutral outlook for the stock.

How to buy Cytokinetics (CYTK) Stock?
Cytokinetics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Cytokinetics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.